Emotion Recognition Modification for Bipolar Disorder

Sponsor
Northwell Health (Other)
Overall Status
Withdrawn
CT.gov ID
NCT02613104
Collaborator
(none)
0
1
4
48
0

Study Details

Study Description

Brief Summary

Previous research suggests that people with bipolar disorder have trouble accurately identifying emotions. The goal of this study is to test a novel intervention, emotion recognition modification (ERM), to help improve the ability of young people with bipolar disorder to identify emotions.

Condition or Disease Intervention/Treatment Phase
  • Other: emotion recognition modification - sad>happy
  • Other: emotion recognition modification - sad>happy control
  • Other: emotion recognition modification - angry>happy
  • Other: emotion recognition modification - angry>happy control
N/A

Detailed Description

Procedure: Participants will be recruited through the University Clinic, affiliated psychiatric hospitals and outpatient psychiatric clinics in the area, and public websites. Interested participants will be interviewed on the phone to determine initial eligibility; those who meet criteria will be invited for a comprehensive evaluation.

For potential participants under the age of 18, parents/caregivers will be asked the eligibility questions about their child. If the child meets initial eligibility criteria, both s/he and the parent/caregiver will be invited to the baseline appointment.

The baseline appointment will take place at Zucker Hillside Hospital. Following the informed consent/assent process, participants will be interviewed by a trained research assistant to assess clinical and treatment history, and to determine diagnostic eligibility, using the SCID. Participants who meet eligibility criteria will proceed to complete other baseline measures.

Emotion recognition baseline procedure. The baseline task allows for the measurement of each participants' baseline balance point, the point at which they are equally likely to see a given face as happy or sad (or angry). Each participant will complete 45 trials of the emotion recognition task in which each face from a morph sequence of happy and sad (or angry) faces is presented, the participant is then forced to decide whether a face is sad (or angry) or happy.

Intervention: Once the baseline measures are completed, participants will be randomized to the sad-to-happy condition, the angry-to-happy condition, or a control condition (n =20 per group). Participants in the intervention conditions will complete the training task three times over three in-person sessions. The task will be similar to the baseline procedure; participants will view faces and be asked to judge the expression, however they will now be given feedback (e.g. "Incorrect! That face was happy."), in order to shift the category of happy faces to include those faces two morph steps beyond the participant's baseline balance point. Participants in the control condition will repeat the baseline task, with feedback consistent with their baseline performance (i.e. the faces they judged as happy initially will be called "correct" when judged happy again. The intervention will be administered a total of three times (once at baseline, once at the first follow-up, once at the second follow-up).

Follow-Up: After the final training session, participants will complete the first follow-up. This will consist of the clinician-administered YMRS, as well as online questionnaires, including the LEE, PANAS, GBI, social network task, Perceived Social Support, feasibility questionnaire.

Eight weeks after completing the final training session, participants will return to the research lab for the final follow-up, which will include the following measures, LEE, PANAS, GBI, social network task, Perceived Social Support, emotion recognition task, YMRS, and BDI-II to assess changes in mood episode over the study follow-up period. Participants will also be asked to complete a brief form about whether they liked the intervention and found it convenient to assess burden and feasibility.

Study Design

Study Type:
Interventional
Actual Enrollment :
0 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Participant)
Primary Purpose:
Treatment
Official Title:
Emotion Recognition Modification for Bipolar Disorder
Study Start Date :
Oct 1, 2014
Actual Primary Completion Date :
Oct 1, 2018
Actual Study Completion Date :
Oct 1, 2018

Arms and Interventions

Arm Intervention/Treatment
Experimental: Sad to Happy

emotion recognition modification - sad>happy

Other: emotion recognition modification - sad>happy
Participants must choose whether each face is happy or sad. Based on these responses, an algorithm then estimates each participant's balance point, the threshold point on the morph sequence at which they are equally likely to label the face as happy or sad. During the intervention, the participant receives feedback on their emotion choices designed to train them to identify two additional morphs as happy, rather than sad. The intervention is completed three times.

Placebo Comparator: Sad control

emotion recognition modification - sad>happy control

Other: emotion recognition modification - sad>happy control
Participants must choose whether each face is happy or sad. Based on these responses, an algorithm then estimates each participant's balance point, the threshold point on the morph sequence at which they are equally likely to label the face as happy or sad. During the placebo intervention, the participant receives feedback on their emotion choices designed to reinforce their initial emotion choices. The placebo intervention is completed three times.

Experimental: Angry to Happy

emotion recognition modification - angry>happy

Other: emotion recognition modification - angry>happy
Participants must choose whether each face is happy or angry. Based on these responses, an algorithm then estimates each participant's balance point, the threshold point on the morph sequence at which they are equally likely to label the face as happy or angry. During the intervention, the participant receives feedback on their emotion choices designed to train them to identify two additional morphs as happy, rather than angry. The intervention is completed three times.

Placebo Comparator: Angry control

emotion recognition modification - angry>happy control

Other: emotion recognition modification - angry>happy control
Participants must choose whether each face is happy or angry. Based on these responses, an algorithm then estimates each participant's balance point, the threshold point on the morph sequence at which they are equally likely to label the face as happy or angry. During the placebo intervention, the participant receives feedback on their emotion choices designed to reinforce their initial emotion choices. The placebo intervention is completed three times.

Outcome Measures

Primary Outcome Measures

  1. change in face emotion recognition as assessed by the number of face emotions correctly identified [two months after the completion of the intervention]

    Ratio of faces identified as happy versus sad/angry

Secondary Outcome Measures

  1. change in self reported depressed mood as measured by baseline and post intervention [following three sessions of the intervention (approximately two weeks)]

    General Behavior Inventory

  2. change in clinician-rated depressed mood as measured by baseline and post intervention scores o [following three sessions of the intervention (approximately two weeks)]

    Beck Depression Inventory

  3. change in self-reported depressed mood as measured by baseline and two month follow-up scores [two months after completion of intervention]

    General Behavior Inventory

  4. change in clinician-rated depressed mood as measured by baseline and two month follow-up scores [two months after completion of intervention]

    Beck Depression Inventory

  5. change in social functioning as measured by the social network questionnaire [following three sessions of the intervention (approximately two weeks)]

    Social network questionnaire

  6. change in social functioning as measured by the social network questionnaire at follow-up [two months after completion of intervention]

    Social network questionnaire

  7. change in positive affect as measured by the Positive and Negative Affect Scale [following three sessions of the intervention (approximately two weeks)]

    PANAS

  8. change in positive affect as measured by the Positive and Negative Affect Scale at follow-up [two months after completion of intervention]

    PANAS

Eligibility Criteria

Criteria

Ages Eligible for Study:
16 Years to 25 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Aged 16-25 with a bipolar spectrum disorder. Must be English-speaking.
Exclusion Criteria:
  • Participants who have cognitive impairment, current psychosis, current suicidal intent, or current substance use disorder will be excluded.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Zucker Hillside Hospital Glen Oaks New York United States 11004

Sponsors and Collaborators

  • Northwell Health

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Anna Van Meter, Assistant Professor, Northwell Health
ClinicalTrials.gov Identifier:
NCT02613104
Other Study ID Numbers:
  • 2013-2811
First Posted:
Nov 24, 2015
Last Update Posted:
Oct 6, 2021
Last Verified:
Oct 1, 2021
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 6, 2021